Vo2 Cap Holding AB (publ) has been approved for listing on Nasdaq First North Growth Market (Cision)
![](https://mb.cision.com/Public/20816/3393439/b58df4f132beb859_800x800ar.jpg)
Current company Curando Nordic AB (publ) ("Curando / Bolaget") which is planned to be renamed to Vo2 Cap Holding AB (publ) has applied for and received a conditional approval for trading on the Nasdaq First North Growth Market (“Nasdaq”).
INFORMATION IN THIS PRESS RELEASE IS NOT FOR PUBLICATION, RELEASE, OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, CANADA, SINGAPORE, or any other jurisdiction where such publication or distribution would violate applicable laws or regulations. SEE THE "IMPORTANT INFORMATION" SECTION AT THE END OF THIS PRESS RELEASE.
As previously announced, Curando Nordic AB has entered into an agreement to acquire all shares in Vo2 Cap AB in a so-called reverse acquisition and to transfer Curando's current operations to a wholly-owned subsidiary. As announced on July 15, 2021, the transfer of Curando's current operations has been transferred to the wholly owned subsidiary Agilit Holding AB.
Nasdaq's approval is also conditional on the Company publishing a company description, fulfilling the dissemination requirement, updating its website in accordance with the regulations and that no new significant events occur in the Company that may give rise to a different assessment of Nasdaq.
The company description for Vo2 Cap Holding AB (publ) is intended to be published in good time before the Extraordinary General Meeting on August 17, 2021.
Important information
The information in this press release does not constitute an offer to acquire, subscribe or otherwise trade in shares or other securities in the Company. No action has been taken and no action will be taken to allow an offer to the public in any jurisdiction other than Sweden. Invitation to the persons concerned to subscribe for shares in the Company will only take place through the information memorandum that the Company expects to publish.
The information in this press release may not be published, published or distributed, directly or indirectly, within or to the United States, Canada, Australia, Japan, Hong Kong, Switzerland, New Zealand, Singapore, South Africa or any other jurisdiction where such action would be illegal, subject to legal restrictions or require measures other than those that follow from Swedish law. Measures in violation of these instructions may constitute a breach of applicable securities laws.
No shares or other securities of the Company have been registered, and no shares or other securities will be registered, under the then-current United States Securities Act of 1933 ("US Securities Act") or the securities laws of any state or other jurisdiction in the United States and may not be offered, sold or otherwise transferred, directly or indirectly, in or to the United States, except in accordance with an applicable exemption from, or in a transaction not covered by, the US Securities Act Registration Requirements and in accordance with the securities laws of state or other jurisdiction of the United States.
This press release may contain certain forward-looking information that reflects the Company's current views on future events as well as financial and operational developments. Words that "refer", "assess", "expect", "can", "plan", "consider", "appreciate" and other expressions that indicate indications or predictions regarding future developments or trends, and that are not based on historical facts, constitute forward-looking information. Forward-looking information is inherently associated with both known and unknown risks and uncertainties because it is dependent on future events and circumstances. Forward-looking information does not constitute a guarantee regarding future results or development and the actual outcome may differ materially from what is stated in forward-looking information.
This information is such that Curando is required to publish in accordance with the EU Market Abuse Regulation (EU No. 596/2014). The information was submitted, through the care of the specified contact person, for publication on August 7, 2021.
Tags: